Tradegate
13.05.26 | 20:24
2,980 Euro
+0,68 % +0,020
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,900 | 3,000 | 10:31 | |
| 2,940 | 2,980 | 10:30 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | BTIG senkt Kursziel für Exagen auf 8 US-Dollar, bestätigt aber 'Buy'-Rating | 1 | Investing.com Deutsch | ||
| Di | Exagen stock price target lowered to $8 by BTIG on valuation | 1 | Investing.com | ||
| Di | Exagen reaffirms $70M-$73M 2026 revenue guidance as it targets $600-$650 ASP over time | 1 | Seeking Alpha | ||
| Mo | Exagen Inc. (XGN) Reports Q1 Loss, Beats Revenue Estimates | 1 | Zacks | ||
| Mo | Exagen: EPS übertrifft Schätzungen um 0,05 $ - Umsatz besser als erwartet | 1 | Investing.com Deutsch | ||
| EXAGEN Aktie jetzt für 0€ handeln | |||||
| Mo | EXAGEN INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| Mo | Exagen beats top-line and bottom-line estimates; reaffirms FY26 outlook | 1 | Seeking Alpha | ||
| Mo | Exagen Inc. Reports First Quarter 2026 Results | 124 | GlobeNewswire (Europe) | CARLSBAD, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2026... ► Artikel lesen | |
| Mo | EXAGEN INC. - 8-K, Current Report | - | SEC Filings | ||
| 13.04. | Does Exagen (XGN)'s 200%+ Upside Potential Make It One of the Best Penny Stocks Set to Explode? | 2 | Insider Monkey | ||
| 10.03. | Exagen outlines $70M-$73M 2026 revenue target while expanding sales force and innovation cadence | 1 | Seeking Alpha | ||
| 10.03. | BTIG cuts Exagen stock price target to $9 on lower revenue outlook | 1 | Investing.com | ||
| 10.03. | Exagen stock maintains Outperform rating at William Blair | 3 | Investing.com | ||
| 10.03. | Exagen: William Blair hält an Outperform-Einstufung fest | 2 | Investing.com Deutsch | ||
| 10.03. | Exagen verfehlt Gewinn- und Umsatzprognose für Q4 2025 - Aktie unter Druck | 3 | Investing.com Deutsch | ||
| 10.03. | EXAGEN INC. - 10-K, Annual Report | 2 | SEC Filings | ||
| 10.03. | Exagen GAAP EPS of -$0.20 misses by $0.01, revenue of $16.63M beats by $0.06M | 2 | Seeking Alpha | ||
| 10.03. | Exagen Earnings Report: Q4 Overview | 4 | Benzinga.com | ||
| 10.03. | Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results | 328 | GlobeNewswire (Europe) | Record full-year total revenue and AVISE CTD average selling price New biomarkers and sales force expansion drove over 11% full-year test volume growth CARLSBAD, Calif., March 10, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 10.03. | EXAGEN INC. - 8-K, Current Report | 2 | SEC Filings |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,844 | +0,72 % | Teladoc Health extends rally to seventh straight session, gaining 22% | ||
| INMODE | 11,890 | -0,79 % | InMode LTD.: InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase | YOKNEAM, Israel, May 6, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| BAXTER | 15,185 | +2,74 % | BAXTER INTERNATIONAL INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| HENRY SCHEIN | 59,00 | -0,84 % | Henry Schein Inc. Q1 Sales Increase | MELVILLE (dpa-AFX) - Henry Schein Inc. (HSIC) reported a profit for first quarter of $107 millionThe company's bottom line came in at $107 million, or $0.92 per share. This compares with $110... ► Artikel lesen | |
| DENTSPLY SIRONA | 8,978 | +0,54 % | DENTSPLY SIRONA Inc.: Dentsply Sirona Reports First Quarter 2026 Results | News Summary Reported net sales of $880 millionDelivered GAAP gross margin of 48.5%, GAAP net loss per share of ($0.05)Achieved adjusted gross margin of 50.7%, adjusted EBITDA margin of 14.7%: adjusted... ► Artikel lesen | |
| PETMED EXPRESS | 1,940 | +0,05 % | PetMed Express, Inc.: PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels | DELRAY BEACH, Fla., April 22, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., doing business as PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced a strategic partnership with... ► Artikel lesen | |
| TANDEM DIABETES | 11,900 | -1,65 % | Benchmark initiates Tandem Diabetes stock with Hold on channel shift | ||
| ORGANON | 11,380 | -0,04 % | Organon & Co.: Europäische Kommission erteilt Marktzulassung für POHERDY (Pertuzumab) von Henlius und Organon, das erste in Europa zugelassene Biosimilar zu PERJETA (Pertuzumab) | Shanghai Henlius Biotech, Inc. (2696.HK) und Organon (NYSE: OGN) gaben heute bekannt, dass die Europäische Kommission die Zulassung für POHERDY (Pertuzumab) 420 mg/14 ml Injektion zur intravenösen... ► Artikel lesen | |
| QUIDELORTHO | 9,532 | +0,95 % | Jefferies cuts Quidel stock rating on earnings visibility concerns | ||
| AMBU | 8,435 | +0,18 % | Ambu A/S: Interim Report For Q1 2025/26 | 4.2.2026 07:04:05 CET | Ambu A/S |
Interim report (Q1 and Q3)
Ambu had a solid start to the 2025/26 financial year, reflected by continued strong growth momentum. Endoscopy Solutions grew by 14.4%... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,080 | +1,32 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 10-Q, Quarterly Report | ||
| SENSEONICS | 4,840 | +2,98 % | H.C. Wainwright cuts Senseonics stock price target on dilution | ||
| WORK MEDICAL TECHNOLOGY GROUP | 2,720 | -1,45 % | WORK Medical Technology Group Is Trending Overnight - Here's Why WOK Stock Surged Over 69% In After-Hours Session | ||
| ALIGNMENT HEALTHCARE | 18,255 | -0,08 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 56,52 | +0,04 % | Recent Price Trend in BrightSpring Health Services, Inc. (BTSG) is Your Friend, Here's Why |
Das Unternehmen EXAGEN INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,68 % bei einem Aktienkurs von 2,980 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXAGEN INC finden Sie auf Wallstreet Online.